We are live on ! Find out more
SCA

Stonebridge Capital Advisors Portfolio holdings

AUM $1.43B
1-Year Est. Return 21.98%
This Fund
S&P 500
This Quarter Est. Return
-11.66%
1 Year Est. Return
+21.98%
3 Year Est. Return
+64.22%
5 Year Est. Return
+80.67%
10 Year Est. Return
+293.7%
AUM
$825M
AUM Growth
-$100M
Cap. Flow
+$20.7M
Cap. Flow %
2.51%
Top 10 Hldgs %
24.59%
Holding
1,119
New
60
Increased
193
Reduced
253
Closed
162

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$7.4M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.44M
3
HD icon
Home Depot
HD
+$4.7M
4
CRM icon
Salesforce
CRM
+$4.6M
5
BLK icon
Blackrock
BLK
+$2.46M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.66M
2
CSCO icon
Cisco
CSCO
+$6.51M
3
CVX icon
Chevron
CVX
+$3.05M
4
T icon
AT&T
T
+$2.28M
5
IVZ icon
Invesco
IVZ
+$2.02M

Sector Composition

Rank Sector Weight
1 Technology 16.78%
2 Healthcare 13.57%
3 Financials 12.18%
4 Consumer Staples 10.33%
5 Communication Services 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWA icon
676
BorgWarner
BWA
$13.1B
$6K ﹤0.01%
214
+2
+0.9% +$66
CCD
677
Calamos Dynamic Convertible & Income Fund
CCD
$707M
$6K ﹤0.01%
300
COF icon
678
Capital One
COF
$128B
$6K ﹤0.01%
61
-42
-41% -$5.13K
CUZ icon
679
Cousins Properties
CUZ
$5.19B
$6K ﹤0.01%
202
DELL icon
680
Dell
DELL
$262B
$6K ﹤0.01%
126
-66
-34% -$3.12K
GMED icon
681
Globus Medical
GMED
$10.7B
$6K ﹤0.01%
100
HACK icon
682
Amplify Cybersecurity ETF
HACK
$2.68B
$6K ﹤0.01%
125
IFF icon
683
International Flavors & Fragrances
IFF
$20.2B
$6K ﹤0.01%
51
ISRG icon
684
Intuitive Surgical
ISRG
$127B
$6K ﹤0.01%
30
-15
-33% -$3.52K
JBHT icon
685
JB Hunt Transport Services
JBHT
$25.5B
$6K ﹤0.01%
41
-197
-83% -$33.3K
MAIN icon
686
Main Street Capital
MAIN
$5.06B
$6K ﹤0.01%
+153
New +$5.98K
MDY icon
687
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$6K ﹤0.01%
14
BINI
688
DELISTED
Bollinger Innovations
BINI
0
NEAR icon
689
iShares Short Maturity Bond ETF
NEAR
$4.83B
$6K ﹤0.01%
+120
New +$5.93K
PBE icon
690
Invesco Biotechnology & Genome ETF
PBE
$281M
$6K ﹤0.01%
100
PSF icon
691
Cohen & Steers Select Preferred & Income Fund
PSF
$234M
$6K ﹤0.01%
300
QYLD icon
692
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.11B
$6K ﹤0.01%
+366
New +$6.89K
REGN icon
693
Regeneron Pharmaceuticals
REGN
$78.5B
$6K ﹤0.01%
10
SCHX icon
694
Schwab US Large- Cap ETF
SCHX
$71.8B
$6K ﹤0.01%
420
-12
-3% -$194
SPGI icon
695
S&P Global
SPGI
$121B
$6K ﹤0.01%
17
TD icon
696
Toronto Dominion Bank
TD
$198B
$6K ﹤0.01%
91
TNDM icon
697
Tandem Diabetes Care
TNDM
$1.34B
$6K ﹤0.01%
100
URA icon
698
Global X Uranium ETF
URA
$5.42B
$6K ﹤0.01%
340
-2,600
-88% -$58.5K
WCC
699
WESCO International
WCC
$16.7B
$6K ﹤0.01%
54
CRL icon
700
Charles River Laboratories
CRL
$11.2B
$5K ﹤0.01%
25

Similar funds

Stonebridge Capital Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Stonebridge Capital Advisors held 1,119 positions worth $825M, down 11% from $926M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Stonebridge Capital Advisors's Q2 2022 filing shows 60 new, 193 increased, 253 reduced and 162 closed positions. Its largest new stake was Winmark: 10,470 shares worth $2.05M. The largest sale was AbbVie, an estimated $7.66M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • Stonebridge Capital Advisors's largest Q2 2022 buy was Winmark: 10,470 shares worth $2.05M.
  • Stonebridge Capital Advisors added most to Oracle in Q2 2022, an estimated $7.4M increase.
  • Stonebridge Capital Advisors's biggest Q2 2022 reduction was AbbVie, cutting an estimated $7.66M.
  • Stonebridge Capital Advisors fully exited Hartford Multifactor Developed Markets ex-US ETF in Q2 2022, selling an estimated $215K.
  • Stonebridge Capital Advisors's ten largest holdings make up 25% of its $825M portfolio in Q2 2022.
  • Stonebridge Capital Advisors opened 60 new positions and closed 162 in Q2 2022.
  • Stonebridge Capital Advisors's portfolio value fell 11% quarter-over-quarter to $825M.

Based on Stonebridge Capital Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.